ACUVUE® Abiliti™ Overnight and ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management

FDA Premarket Approval P990018 S006

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for addition of the following private label trade names for the menicon z night (tisilfocon a) contact lenses for overnight wear: acuvue® abiliti™ overnight and acuvue® abiliti™ overnight therapeutic lenses for myopia management

DeviceACUVUE® Abiliti™ Overnight and ACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management
Generic NameLens, Contact, Orthokeratology, Overnight
ApplicantMENICON CO. LTD.
Date Received2021-01-21
Decision Date2021-05-06
PMAP990018
SupplementS006
Advisory CommitteeOphthalmic
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address MENICON CO. LTD. 21-19, Aoi 3-chome, Naka-ku nagoya Aichi 460-0-0006

Supplemental Filings

Supplement NumberDateSupplement Type
P990018Original Filing
S008 2022-02-07 Normal 180 Day Track
S007
S006 2021-01-21 Normal 180 Day Track No User Fee
S005 2018-11-28 Normal 180 Day Track
S004 2009-04-01 Normal 180 Day Track No User Fee
S003 2002-10-21 Real-time Process
S002 2001-11-28 Panel Track
S001 2000-07-28 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.